Physician drug prescribing preferences and availability for ventilation of patients with COVID-19

Ian Coombes; Michael Dooley; Shane  Townsend; Sinead Carmichael; Susan G. Poole; Nermin Karamujic; Brent  Richards; Marc D. Ziegenfuss; Melissa Ankrvas; Hailie Uren; Jason Roberts; Anthony  Holley

Physician drug prescribing preferences and availability for ventilation of patients with COVID-19

Ian Coombes, Michael Dooley, Shane Townsend, Sinead Carmichael , Susan G. Poole, Nermin Karamujic, Brent Richards, Marc D. Ziegenfuss, Melissa Ankrvas, Hailie Uren, Jason Roberts, Anthony Holley

Centre for Medicine Use and Safety

Research output: Contribution to journal › Article › Other › peer-review

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many international health care systems, with a high number of patients having severe respiratory failure. The mainstay of treatment for these patients is invasive mechanical ventilation requiring pharmacological induction, followed by ongoing sedation and analgesia. In the setting of severe acute respiratory failure, neuromuscular blockade is often required.

Original language	English
Pages (from-to)	271-274
Number of pages	4
Journal	Critical Care and Resuscitation
Volume	22
Issue number	3
Publication status	Published - 1 Sept 2020

Cite this

@article{33485225e12348c482765105d0452c61,

title = "Physician drug prescribing preferences and availability for ventilation of patients with COVID-19",

abstract = "The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many international health care systems, with a high number of patients having severe respiratory failure. The mainstay of treatment for these patients is invasive mechanical ventilation requiring pharmacological induction, followed by ongoing sedation and analgesia. In the setting of severe acute respiratory failure, neuromuscular blockade is often required.",

author = "Ian Coombes and Michael Dooley and Shane Townsend and Sinead Carmichael and Poole, {Susan G.} and Nermin Karamujic and Brent Richards and Ziegenfuss, {Marc D.} and Melissa Ankrvas and Hailie Uren and Jason Roberts and Anthony Holley",

year = "2020",

month = sep,

day = "1",

language = "English",

volume = "22",

pages = "271--274",

journal = "Critical Care and Resuscitation",

issn = "1441-2772",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Physician drug prescribing preferences and availability for ventilation of patients with COVID-19

AU - Coombes, Ian

AU - Dooley, Michael

AU - Townsend, Shane

AU - Carmichael , Sinead

AU - Poole, Susan G.

AU - Karamujic, Nermin

AU - Richards, Brent

AU - Ziegenfuss, Marc D.

AU - Ankrvas, Melissa

AU - Uren, Hailie

AU - Roberts, Jason

AU - Holley, Anthony

PY - 2020/9/1

Y1 - 2020/9/1

N2 - The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many international health care systems, with a high number of patients having severe respiratory failure. The mainstay of treatment for these patients is invasive mechanical ventilation requiring pharmacological induction, followed by ongoing sedation and analgesia. In the setting of severe acute respiratory failure, neuromuscular blockade is often required.

AB - The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many international health care systems, with a high number of patients having severe respiratory failure. The mainstay of treatment for these patients is invasive mechanical ventilation requiring pharmacological induction, followed by ongoing sedation and analgesia. In the setting of severe acute respiratory failure, neuromuscular blockade is often required.

M3 - Article

SN - 1441-2772

VL - 22

SP - 271

EP - 274

JO - Critical Care and Resuscitation

JF - Critical Care and Resuscitation

IS - 3

ER -